ASP Isotopes Inc. (ASPI)
ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.
Sector: Miscellaneous Chemical Products
Industry: Chemicals - Specialty
ASP Isotopes Inc. Common Stock
ASP Isotopes Inc. (ASPI) dilution facts from SEC filings
Snapshot as of Sep 30, 2026, built from 52 SEC filings.
- Shelf registration
- S-3ASR filed Jul 16, 2026, effective Jul 16, 2026
- Source: S-3ASR filed Jul 16, 2026
- At-the-market (ATM) program
- No active program in the filings reviewed
- Warrants outstanding
- 1 warrant series recorded as outstanding
Check another stock for dilution
Facts as recorded in the company's SEC filings. The full snapshot, with instrument terms, share counts and history, is part of Signal8 Pro.